SMA Solar (S92) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
H1 2025 sales declined to €684.9–685 million from €759 million year-over-year, with Large Scale & Project Solutions growing and Home & Business Solutions (HBS) declining sharply due to lower demand and price pressure.
EBITDA dropped to €9–9.1 million (1.3% margin) from €80.6–81 million (10.6%) in H1 2024, impacted by significant one-time effects including inventory write-offs and provisions.
Free cash flow improved to €66 million from -€203 million year-over-year, driven by net working capital reduction.
Order backlog decreased to €1,161–1,161.4 million, reflecting softer demand in HBS and the US.
Restructuring and transformation programs are underway, targeting €150–200 million EBIT improvement, with more than half expected by 2025.
Financial highlights
EBITDA margin fell to 1.3% from 10.6% year-over-year; gross margin declined to 18.2% from 26.0% due to product mix and inventory write-downs.
Net cash increased to €135 million at H1 end, mainly from working capital improvements; financial liabilities halved to €70 million.
Net working capital reduced to €283 million (19.4% of sales LTM), below the targeted 23–27% range.
Cash flow from operating activities was €90 million, a strong turnaround from -€174 million last year.
Investments rose to €80.1 million, mainly for new production capacity.
Outlook and guidance
2025 sales guidance narrowed to €1,500–1,550 million; EBITDA expected at €70–80 million, with sales and EBITDA at the lower end due to soft HBS demand and macro uncertainty.
Large Scale & Project Solutions sales expected slightly above 2024; HBS sales to decline significantly.
Capital expenditure for 2025 forecast at ~€115 million, focused on new products and digital solutions.
Further write-downs possible if HBS business deteriorates.
Ongoing restructuring and cost optimization measures to support profitability.
Latest events from SMA Solar
- 2025 revenue flat, losses from one-offs, cash flow up, 2026 outlook cautious on tariffs.S92
Q4 202526 Mar 2026 - Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025